¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Human mutation."¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
human leukocyte antigen
»ç¶÷¹éÇ÷±¸Ç׿ø
human leukocyte antigen complex
»ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕü
human leukocyte antigen complex gene
»ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕüÀ¯ÀüÀÚ
human menopausal gonadotropin
»ç¶÷Æó°æ»ý½Ä»ùÀÚ±ØÈ£¸£¸ó, »ç¶÷Æó°æ¼º¼±ÀÚ±ØÈ£¸£¸ó
human papilloma virus
»ç¶÷À¯µÎÁ¾¹ÙÀÌ·¯½º
human papilloma virus test
»ç¶÷À¯µÎÁ¾¹ÙÀÌ·¯½º°Ë»ç
human placental lactogen
»ç¶÷ŹÝÁ¥»ùÀÚ±ØÈ£¸£¸ó, »ç¶÷ŹݶôÅä°Õ
human plasma protein fraction
»ç¶÷Ç÷Àå´Ü¹éºÐÀ²
human rabies immune globulin
»ç¶÷¹ÌÄ£°³º´¸é¿ª±Û·ÎºÒ¸°, »ç¶÷±¤°ßº´¸é¿ª±Û·ÎºÒ¸°
human T-cell lymphoma/leukemic virus
»ç¶÷T¼¼Æ÷¸²ÇÁÁ¾/¹éÇ÷º´¹ÙÀÌ·¯½º
human T-cell lymphotropic virus
»ç¶÷T¼¼Æ÷¸²ÇÁģȹÙÀÌ·¯½º
immune human serum globulin
¸é¿ª»ç¶÷Ç÷û±Û·ÎºÒ¸°
normal human plasma
Á¤»ó»ç¶÷Ç÷Àå
allelic mutation
¸Â¼¶µ¹¿¬º¯ÀÌ, ´ë¸³µ¹¿¬º¯ÀÌ
back mutation
¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
back mutation
¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
chromosomal mutation
¿°»öüº¯ÀÌ, ¿°»öüµ¹¿¬º¯ÀÌ
cold-sensitive mutation
Àú¿Â¹Î°¨µ¹¿¬º¯ÀÌ
conditional mutation
Á¶°Çµ¹¿¬º¯ÀÌ
conditional lethal mutation
Á¶°ÇÄ¡»çµ¹¿¬º¯ÀÌ
dominant mutation
¿ì¼ºµ¹¿¬º¯ÀÌ
drift mutation
¿¬¼Óº¯ÀÌ
mutation detection
µ¹¿¬º¯À̰ËÃâ
extragenic suppressor mutation
À¯ÀüÀڿܹßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
forward mutation
ÀüÇâµ¹¿¬º¯ÀÌ
frequency mutation
µ¹¿¬º¯À̺óµµ
genetic mutation
À¯Àüµ¹¿¬º¯ÀÌ
genomic mutation
À¯ÀüÀÚµ¹¿¬º¯ÀÌ, À¯Àüüµ¹¿¬º¯ÀÌ
mutation genetics
º¯ÀÌÀ¯ÀüÇÐ
host range mutation
¼÷ÁÖ¹üÀ§º¯ÀÌ, ¼÷ÁÖ¿ªº¯ÀÌ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
HCG=>human chorionic gonadotropin
»ç¶÷À¶¸ð¼º ¼º¼±ÀÚ±ØÈ£¸£¸ó
HIV => human immunodeficiency virus
»ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º
HIV=>human immunodeficiency virus
ÀÎü ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º
HLA => human leukocyte antigen
ÀÎüÁ¶Á÷ÀûÇÕÇ׿ø<ÀÎü¹éÇ÷±¸Ç׿ø>
HLA= human leukocyte antigen ; hist ocompatibility antigens ; tran splan tation antigens
HLA<Á¶Á÷ÀûÇÕÀ̽Ä>Ç׿ø, ÀιéÇ÷±¸Ç׿ø.
HLA= human leukocyte antigen ; histocompatibility antigens ; transplantation anti
HLA<Á¶Á÷ÀûÇÕÀ̽Ä>Ç׿ø, »ç¶÷¹éÇ÷±¸Ç׿ø.
HPV=>human papilloma virus
ÀÎü À¯µÎÁ¾¹ÙÀÌ·¯½º
HTLV => human T lymphotropic virus
»ç¶÷ T ¸²ÇÁģȼº ¹éÇ÷º´
Human chorionic thyrotropin
ÀÎÀ¶¸ð¸·¼ºÅ¸ÀÌ·ÎÆ®·ÎÇÉ
Human immunodeficiency virus = HIV
»ç¶÷¸é¿ª°áÇ̼º ¹ÙÀÌ·¯½º
Human placental lactogen
ŹÝÀ¯¼±ÀÚ±Ø(÷ÃÚïêáàÍí©Ð½)È£¸£¸ó
antigen, human leukocyte (HLA)
»ç¶÷ ¹éÇ÷±¸Ç׿ø, HLAÇ׿ø
hCG (Human chorionic gonadotropin)
ÀÎÀ¶¸ð¸·¼º°í³ªµµÆ®·ÎÇÉ
human Herpesvirus 6 (HHV-6)
Á¦6Çü »ç¶÷ Ç츣Æä½º¹ÙÀÌ·¯½º
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
gene mutation
À¯ÀüÀÚ(µ¹¿¬)º¯ÀÌ
genetic mutation
À¯ÀüÀû µ¹¿¬º¯ÀÌ
genomic mutation
À¯ÀüÀÚµ¹¿¬º¯ÀÌ
host range mutation
¼÷ÁÖ¿ªº¯ÀÌ
induced mutation
À¯¹ß¼º µ¹¿¬º¯ÀÌ.
induced mutation
À¯¹ßµ¹¿¬º¯ÀÌ
lethal mutation
Ä¡»çµ¹¿¬º¯ÀÌ(¡ÔÍæ×ܨì¶).
lethal mutation
Ä¡»ç µ¹¿¬º¯ÀÌ
loss mutation
»ó½Çµ¹¿¬º¯ÀÌ(ßÃã÷ÔÍæÔܨì¶).
missense mutation
°ú¿Àµ¹¿¬º¯ÀÌ(Φè¦ÔÍæÔܨì¶).
multiple allelic mutation
º¹´ë¸³ÇüÁúº¯ÀÌ(ÜÜÓßí¡û¡òõܨì¶).
mutation
(µ¹¿¬)º¯ÀÌ(ÔÍæÔܨì¶)
mutation detection
(µ¹¿¬)º¯À̰ËÃâ
mutation disturbance
º¯¼ºÀå¾Ö(ܨàõî¡äô).
mutation genetics
º¯ÀÌÀ¯ÀüÇÐ(ܨì¶ë¶îîùÊ).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½